alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## NUMBER 13

- 2 2

- 00 2 74

- C V

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI

– EDINBURG

JORGE AGUILAR ZANNATA, Appellant,

V.

PH QUALITY PRODUCE, LLC , Appellee.

On appea l from the County Court at Law No. 7 of Hidalgo C ounty, Texas.



## MEMORANDUM OPINION

Before Chief Justice Contreras and Justices Longoria and Tijerina Memorandum Opinion by Justice Longoria

On June 15 , 2022 , a ppellant Jorge Aguilar Zannata filed a notice of appeal

regarding a final judgment rendered in favor of appellee PH Quality Produce, LLC. On

June 2 1 , 222, the Clerk of this Court requested appellant to remit the $205.00 filing fee

for the appeal within ten days. See T EX

. R. A PP

. P. 5 (“ A party who is not excused by2 statute or these rules from paying costs must pay

— at the time an item is presented for

filing

— whatever fees are required by statute or Supreme Court order. The appellate court

may enforce this rule by any order that is just. ”); T EX

. G OV ' T C ODE A NN

. § 51.207

( delineating the required fees and costs in an appellate court ). Appellant did not pay the

filing fee

.
On July 14 , 2022, the Clerk notified appellant that he was delinquent in paying the

filing fee for the appeal . The Clerk advised appellant that the appeal would be dismissed

if the filing fee was not paid within ten d ays. See id. R. 42.3(c). Appellant did not pay the

filing fee.

The Court, having examined and fully considered the notice of appeal and

subsequent events, is of the opinion that this appeal should be dismissed. This Court has

the authority to dismiss an appeal because the appellant has failed to comply with a

requirement of the appellate rules, a court order, or a notice from the clerk requiring a

response or other action within a specified time. See T EX

. R. A PP

. P. 4 2.3(c); Smith v. DC

Civil Constr., LLC , 521 S.W.3d 75, 76 (Tex. App.

— San Antonio 2017, no pet.). Here,

appellant has not paid the appellate filing fee or otherwise responded to the Clerk’s

directives. Accordingly, w e dismiss this appeal. See T EX

. R. A PP

. P. 42.3(c)

.

NORA L. LONGORIA Justice

Delivered and filed on the 25th day of August, 2022.
Exhibit 32.1
 
 Certification
Pursuant to 18 U.S.C. Section 1350,
 
 As
Adopted Pursuant to
 
 Section
906 of the Sarbanes-Oxley Act of 2002
 
 
 In
connection with the Quarterly Report of Imagin Molecular Corporation (the
“Registrant”) on Form 10-Q for the fiscal quarter ended September 30, 2009 as
filed with the Securities and Exchange Commission on the date hereof (the
“Report”), Joseph G. Oliverio, as Chief Executive Officer hereby certifies,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 that:
 
 (1)  The
Report fully complies with the requirements of section 13 (a) or 15 (d), as
applicable of the Securities Exchange Act of 1934; and
 
 (2)  The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.
 
 
 Dated:
      November 16, 2009
              /s/ Joseph G. OliverioJoseph
      G. OliverioChief
      Executive Officer, Director(principal
      executive officer)
 
 
 A signed
original of this written statement required by Section 906 has been provided to
Imagin Molecular Corporation and will be retained by Imagin Molecular
Corporation and furnished to the Securities and Exchange Commission or its staff
upon request.
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

Daimeon Mosley, 

Plaintiff, 

v. 

Bootleggers Scottsdale LLC, et al., 

Defendants.

No. CV-15-2306-PHX-DKD 

REPORT AND RECOMMENDATION 

TO THE HONORABLE SUSAN R. BOLTON, U.S. DISTRICT COURT JUDGE: 

 Pending before the Court is Plaintiff’s Motion for Judgment by Default Against 

Defendant (Doc. 9). In light of the fact that it remains unsettled in the Ninth Circuit 

whether a Magistrate Judge has jurisdiction over a non-appearing defaulted Defendant, 

IT IS RECOMMENDED that the Presiding District Judge of the Phoenix 

Division enter the Proposed Default Judgment. 

 This recommendation is not an order that is immediately appealable to the Ninth 

Circuit Court of Appeals. Any notice of appeal pursuant to Rule 4(a)(1), Federal Rules 

of Appellate Procedure, should not be filed until entry of the district court’s judgment. 

The parties shall have fourteen days from the date of service of a copy of this 

recommendation within which to file specific written objections with the Court. See, 28 

U.S.C. § 636(b)(1); Rules 72, 6(a), 6(b), Federal Rules of Civil Procedure. Thereafter, 

the parties have fourteen days within which to file a response to the objections. Failure 

timely to file objections to the Magistrate Judge’s Report and Recommendation may 

Case 2:15-cv-02306-DKD Document 10 Filed 03/11/16 Page 1 of 2
- 2 - 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

result in the acceptance of the Report and Recommendation by the district court without 

further review. See United States v. Reyna-Tapia, 328 F.3d 1114, 1121 (9th Cir. 2003). 

Failure timely to file objections to any factual determinations of the Magistrate Judge will 

be considered a waiver of a party’s right to appellate review of the findings of fact in an 

order or judgment entered pursuant to the Magistrate Judge’s recommendation. See Rule 

72, Federal Rules of Civil Procedure. 

 Dated this 11th day of March, 2016. 

cc: SRB 

Case 2:15-cv-02306-DKD Document 10 Filed 03/11/16 Page 2 of 2
#### OUTDOOR WORLD CORPORATION v. NEW JERSEY DEPARTMENT OF LABOR.

September 6, 1989.

Petition for certification denied.
V

105TH CONGRESS

1ST SESSION H. R. 544

For the relief of Henry Johnson.

IN THE HOUSE OF REPRESENTATIVES

FEBRUARY 4, 1997

Mr. MCNULTY introduced the following bill; which was referred to the

Committee on National Security

A BILL

For the relief of Henry Johnson.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That the time limitations specified in section 3744(b) of

4 title 10, United States Code, shall not apply with respect

5 to awarding a medal of honor under section 3741 of such

6 title to Henry Johnson (service number 10-33-48) for acts

7 of heroism during World War I while a sergeant in the

8 United States Army.

Æ
,17+(81,7('67$7(6',675,&7&2857

)257+(',675,&72)$5,=21$

BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB

,15(%$5',9&),/7(56352'8&76  &DVH1RPG'*&

/,$%,/,7</,7,*$7,21 0'/1R BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB

7KLV'RFXPHQW5HODWHGWR3ODLQWLIIV

/$.(<$%$6.20

&LYLO&DVH7FY'*&

ORDER

Considering the Stipulation of Dismissal Without Prejudice of Lakeya Baskom,

IT IS HEREBY ORDERED, ADJUDGED AND DECLARED that all claims of Plaintiff, 

Lakeya Baskom against Defendants C.R. Bard, Inc. and Bard Peripheral Vascular, Inc., in Civil 

Action No. MDL No. 2641 (Member Case 2:17-cv-02427) are dismissed in their entirety without 

prejudice as to the refiling of same, and each party shall bear its own costs.

Signed this _____________day of _________________________, 2017.

____________________________

Honorable David G. Campbell

United States District Court Judge

Case 2:15-md-02641-DGC Document 9226-1 Filed 12/06/17 Page 1 of 2
Case 2:15-md-02641-DGC Document 9226-1 Filed 12/06/17 Page 2 of 2
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA

 

 Before the Court is the parties’ Stipulation for Dismissal (Doc. 43). Pursuant to the 

parties’ stipulation, 

 IT IS ORDERED: 

1. That the Stipulation for Dismissal (Doc. 43) is granted; 

2. That this action is dismissed with prejudice in its entirety; 

3. That each party shall bear its own costs and attorneys’ fees; and 

4. That the Clerk of Court shall terminate this action. 

Dated this 22nd day of August, 2016.

Honorable Steven P. Logan

United States District Judge

Mark Wenzel, 

 

Plaintiff, 

vs. 

Experian Information Solutions, Inc., 

Defendant. 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

)

No. CV-15-02358-PHX-SPL

ORDER 

Case 2:15-cv-02358-SPL Document 44 Filed 08/22/16 Page 1 of 1
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, Robert H. Mullen, certify that: 

 

1. I have reviewed this Quarterly Report on Form 10-Q of The Newark Group, Inc.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, basedon our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

(a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

(b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: December 10, 2004
108TH CONGRESS

2D SESSION S. 2866

AN ACT

To amend the Farm Security and Rural Investment Act

of 2002 to clarify the authority of the Secretary of

Agriculture and the Commodity Credit Corporation to

enter into memorandums of understanding with a State

regarding the collection of approved State commodity

assessments on behalf of the State from the proceeds

of marketing assistance loans.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Commodity Assess5 ment, Protection, and Reform Act’’.
 †

2

S 2866 ES

1 SEC. 2. COLLECTION OF COMMODITY ASSESSMENTS.

2 Subtitle B of title I of the Farm Security and Rural

3 Investment Act of 2002 (7 U.S.C. 7931 et seq.) is amend4 ed by adding at the end the following:

5 ‘‘SEC. 1210. COLLECTION OF COMMODITY ASSESSMENTS.

6 ‘‘(a) DEFINITION OF ASSESSMENT.—In this section,

7 the term ‘assessment’ means funds that are—

8 ‘‘(1) collected with respect to a specific com9 modity in accordance with this Act;

10 ‘‘(2) paid by the first purchaser of the com11 modity in accordance with a State law or this title;

12 and

13 ‘‘(3) not collected through a tax or other rev14 enue collection activity of a State.

15 ‘‘(b) AUTHORITY TO COLLECT COMMODITY ASSESS16 MENTS FROM MARKETING ASSISTANCE LOANS.—The

17 Secretary may collect commodity assessments from the

18 proceeds of a marketing assistance loan made under this

19 subtitle in accordance with an agreement between the Sec20 retary and the State.’’.

Passed the Senate November 21 (legislative day, November 20), 2004.

Attest:

Secretary.
108TH CONGRESS

2D SESSION S. 2866

AN ACT

To amend the Farm Security and Rural Investment

Act of 2002 to clarify the authority of the Secretary of Agriculture and the Commodity CreditCorporation to enter into memorandums of understanding with a State regarding the collectionof approved State commodity assessments on behalf of the State from the proceeds of marketingassistance loans.
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C.SECTION 1350AS ADOPTED PURSUANT TO SECTION 906 OFTHE SARBANES-OXLEY ACT OF 2002

In connection with the QuarterlyReport of Delco Remy International, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rajesh K. Shah, Executive VicePresident and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

|  | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--|-----|-----------------------------------------------------------------------------------------------------------------------|

|  | (2) | The information contained in the Report fairly presents, in all material respects, the financial position and results of operations of the Company. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

 

|      |                                                                          |   |   |   |
|-----------|-------------------------------------------------------------------------------|--------|--------|--------|
| /s/  | RAJESH K. SHAH                                                                |   |   |        |
|           |                                                                               |   |   |   |
|      | **Rajesh K. Shah****Executive Vice President and****Chief Financial Officer** |   |   |   |

 

August 8, 2003

A signed original of this written statement required by Section 906 has been provided to Delco Remy International, Inc. and will be retained by Delco Remy International, Inc. and furnishedto the Securities and Exchange Commission or its staff upon request.
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"NASA","author_url":"https:\/\/www.nasa.gov\/author\/nasamigrate\/","title":"NASA\u2019s Modern History Makers: Ernest Williams","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"0HxE5tK1z1\"><a href=\"https:\/\/www.nasa.gov\/image-detail\/nasas-modern-history-makers-ernest-williams\/\">NASA\u2019s Modern History Makers: Ernest Williams<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/image-detail\/nasas-modern-history-makers-ernest-williams\/embed\/#?secret=0HxE5tK1z1\" width=\"600\" height=\"338\" title=\"“NASA\u2019s Modern History Makers: Ernest Williams” — NASA\" data-secret=\"0HxE5tK1z1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.nasa.gov\/wp-content\/uploads\/2023\/03\/grc-2023-c-00574.jpg?w=600","thumbnail_width":600,"thumbnail_height":900}
3.  EXHIBIT 23





Independent Auditors' Consent




The Board of Directors
MedPlus, Inc.:

We consent to the incorporation by reference in the registration
statements of MedPlus, Inc. and subsidiaries on Form S-8 (No.
33-94426) and Form S-3 (No. 333-20547) of our report dated
February 28, 1997, relating to the consolidated balance sheets of
MedPlus, Inc. and subsidiaries as of December 31, 1996 and 1995,
and the related consolidated statements of operations,
shareholders' equity and cash flows for each of the years in the
three-year period ended December 31, 1996, which report appears in
the December 31, 1996 annual report on Form 10-KSB of MedPlus,
Inc. and subsidiaries.
 

/s/ KPMG Peat Marwick LLP


Cincinnati, Ohio
March 27, 1997
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          34,091
<INT-BEARING-DEPOSITS>                          16,500
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    404,078
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                      1,866,674
<ALLOWANCE>                                     28,455
<TOTAL-ASSETS>                               2,429,729
<DEPOSITS>                                   1,884,634
<SHORT-TERM>                                   337,647
<LIABILITIES-OTHER>                             18,336
<LONG-TERM>                                     43,160
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           205
<OTHER-SE>                                     145,747
<TOTAL-LIABILITIES-AND-EQUITY>               2,429,729
<INTEREST-LOAN>                                114,441
<INTEREST-INVEST>                               24,772
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                               139,213
<INTEREST-DEPOSIT>                              64,262
<INTEREST-EXPENSE>                              81,691
<INTEREST-INCOME-NET>                           57,522
<LOAN-LOSSES>                                    1,500
<SECURITIES-GAINS>                                 256
<EXPENSE-OTHER>                                  8,191
<INCOME-PRETAX>                                 28,443
<INCOME-PRE-EXTRAORDINARY>                      18,161
<EXTRAORDINARY>                                  (871)
<CHANGES>                                            0
<NET-INCOME>                                    17,290
<EPS-BASIC>                                       0.84
<EPS-DILUTED>                                     0.84
<YIELD-ACTUAL>                                    .082
<LOANS-NON>                                      8,235
<LOANS-PAST>                                        50
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                28,297
<CHARGE-OFFS>                                    2,321
<RECOVERIES>                                       979
<ALLOWANCE-CLOSE>                               28,455
<ALLOWANCE-DOMESTIC>                            28,455
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
EXHIBIT 99.7

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER  PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying annual report on Form 40-F of NOVA Chemicals Corporation for the year ended December 31, 2007
(the "Report"), I, Larry A. MacDonald, Chief Financial Officer of NOVA Chemicals Corporation, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002, that:



|March 10, 2008 | /s/LARRY A. MACDONALD                     
|-------------- | ------------------------------------------
|               | Larry A. MacDonald Chief Financial Officer

---



QuickLinks
<PAGE>

                                                                    EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                         PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

     In connection with this quarterly report on Form 10-Q of King
Pharmaceuticals, Inc. I, Joseph Squicciarino, Chief Financial Officer of King
Pharmaceuticals, Inc., certify, pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

          1. The report fully complies with the requirements of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

          2. The information contained in this report fairly presents, in all
     material respects, the financial condition and results of operations of
     King Pharmaceuticals, Inc.

                                                /s/ JOSEPH SQUICCIARINO
                                          --------------------------------------
                                                   Joseph Squicciarino
                                                 Chief Financial Officer

Date: May 9, 2006
#### Public Service Corporation of New Jersey et al., appellants, *v.*Town of Westfield, respondent.

[Submitted December 6th, 1913.

Decided January 29th, 1914.]

On appeal from a decree of the court of chancery advised by Vice-Chancellor Eméry, whose opinion is reported in *80 N. J. Eq. (10 Buck.) 295,*and *ante p. 43'.*

*Mr. Frank Bergen,*for the appellants.

*Mr. Paul Q. Oliver,*for the respondent.

Per Curiam.

The order appealed from will be affirmed, for the reasons stated in the opinion filed in the court below by Vice-Chancellor Emery.

*For*affirmance—The Chief-Justice, Garrison, Swayze, Parker, Bergen, Minturn, Kalisoh, Bogert, AUiedenburgh, Congdon, White, Heppenheimbr—12.

*For*reversal—None.